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Ovary developmentporal translation of diverse mRNAs is essential to guarantee proper oocyte
maturation and early embryogenesis. The eukaryotic translation initiation factor 4E (eIF4E), which binds the
5′ cap structure of eukaryotic mRNAs, associates with either stimulatory or inhibitory factors to modulate
protein synthesis. In order to identify novel factors that might act at the translational level during Drosophila
oogenesis, we have undertaken a functional proteomic approach and isolated the product of the Hsp83 gene,
the evolutionarily conserved chaperone Hsp90, as a speciﬁc component of the cap-binding complex. Here we
report that Hsp90 interacts in vitrowith the translational repressor Cup. In addition, we show that Hsp83 and
cup interact genetically, since lowering Hsp90 activity enhances the oogenesis alterations linked to diverse
cup mutant alleles. Hsp90 and Cup co-localize in the cytoplasm of the developing germ-line cells within
the germarium, thus suggesting a common function from the earliest stages of oogenesis. Taken together, our
data start elucidating the role of Hsp90 during Drosophila female germ-line development and strengthen the
idea that Cup has multiple essential functions during egg chamber development.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIn eukaryotes, translation initiation is facilitated by the 7-methyl-
guanosine cap structure, m7GpppN, which is present on all mRNAs
transcribed in the nucleus (Shatkin, 1976). The cap structure is
recognized by the eukaryotic translation initiation factor 4E (eIF4E),
which also directly binds the eukaryotic translation initiation factor 4Gn factor 4E; m7GTP, 7-methyl-
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rights reserved.(eIF4G), a scaffolding protein aggregating with the 40S ribosome
subunit through an interactionwith the initiation factor eIF3 (Hershey
et al.,1996). According to the closed loopmodel of translation (Wells et
al., 1998), eIF4G, in turn, interacts with the poly(A) binding protein
(PABP), bound to the poly(A) tail present at the 3′ end of the mRNAs,
thus facilitating the recruitment of ribosomes for successive cycles of
translation.
A widespread strategy to regulate eukaryotic translation relies on
the perturbation of the eIF4E–eIF4G protein–protein interaction.
Several proteins are able to interact with eIF4E, through a conserved
eIF4E-binding motif (YxxxxLΦ, where x is any residue and Φ is an
aliphatic one), thus preventing its binding to eIF4G (Richter and
Sonenberg, 2005). The eIF4E-binding proteins (4E-BPs) regulate the
overall translation levels in cells by sequestering the majority of both
free and cap-bound eIF4E (Karim et al., 2001). On the contrary, speciﬁc
translational repressors, all containing eIF4E-binding motifs, exert
their activity on select mRNAs by bridging eIF4E to sequence-speciﬁc
RNA-binding proteins (Richter and Sonenberg, 2005; Vardy and Orr-
Weaver, 2007).
Drosophila Cup is involved in translational repression of at least
three speciﬁc mRNAs: oskar (osk) and gurken (grk) during oogenesis
(Wilhelm et al., 2003; Nakamura et al., 2004; Clouse et al., 2008);
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functions have been linked to the ability of Cup to directly bind eIF4E
and/or 3′-untranslated region (UTR) bound molecules. Furthermore,
Cup appears to control the eIF4E phosphorylation status within the
developing ovary (Zappavigna et al., 2004), thus modulating transla-
tion initiation efﬁciency.
In order to identify novel cap-binding factors that might be
involved in translational control of speciﬁc mRNAswithin the growing
oocyte, we performed a functional proteomic analysis essentially
based on the isolation of protein complexes by afﬁnity chromato-
graphy on m7GTP-Sepharose beads. Using mass spectrometry, we
identiﬁed several proteins in these cap-binding complexes, including
the product of the Hsp83 gene (the evolutionarily conserved
chaperone Hsp90). In Drosophila, the functions of Hsp90 have been
extensively studied during male germ-line development (Castrillon et
al., 1993; Yue et al., 1999). However, very little is known about Hsp90
functions in the ovary (Ding et al., 1993; Yue et al., 1999).
In this report, we show that Hsp90 binds the translational
repressor Cup in vitro. Interestingly, Hsp83 mutant alleles, similarly
to cup mutant alleles, display a series of ovarian defects. We further
demonstrate that a genetic interaction between cup and Hsp83 occurs
in vivo: reducing Hsp83 activity speciﬁcally deteriorates the ovarian
defects associated with different cup mutants. Cup and Hsp90 co-
localize within the cytoplasm of developing female germ-line cells in
the germarium and at later stages of oogenesis. Our results begin to
shed light on Hsp90 functions during Drosophila female germ-line
development and reinforce the concept that Cup has different
essential roles during oogenesis (Piccioni et al., 2005).
2. Materials and methods
2.1. Cap-binding analysis
Cap-binding analysis was performed using m7GTP-Sepharose
beads (Amersham) according to Zapata et al. (1994), with the
following modiﬁcations. Total protein extracts, derived from 10
wild-type ovary pairs, were pre-cleared in the presence of 30 μl of
50% slurry 4B-Sepharose beads (Amersham) for 1 h in binding
buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 2.5 mM EGTA, 1 mM
EDTA, 0.1% Tween-20) supplemented with a cocktail of protease
inhibitors (Roche). The protein extracts were recovered by centri-
fugation (300×g for 5 min), added to 30 μl of 50% slurry m7GTP-
Sepharose beads and, then, gently mixed for 2 h. Beads were
collected by centrifugation (300×g for 5 min), washed ﬁve times
with binding buffer and one time with the same buffer, supple-
mented with 0.1 mM GTP, to eliminate non-speciﬁc bound proteins.
Proteins bound to the cap structure were eluted by boiling in
standard Laemmli buffer, supplemented with 100 mM DTT,
separated by SDS-PAGE, and analyzed by mass spectrometry. All
steps of the above experimental procedure were performed at 4 °C.
Proteins bound to the 4B-Sepharose beads, during the pre-clearing
step described above, were also eluted and analyzed as negative
controls.
Protein bands, visualized by colloidal Coomassie, were excised
from the gel, reduced, alkylated with iodoacetamide and digested
with trypsin as previously described (Havlis et al., 2003). Peptide
mixtures were extracted from the gel and analyzed by nano-
chromatography tandem mass spectrometry (nanoLC–MS/MS) on a
CHIP MS Ion Trap XCT Ultra equipped with a capillary 1100 HPLC
system and a chip cube (Agilent Technologies, Palo Alto, CA). Peptide
analysis was performed using data-dependent acquisition of one MS
scan (mass range from 400 to 2000 m/z) followed by MS/MS scans of
the three most abundant ions in each MS scan. Raw data from
nanoLC–MS/MS analyses were employed to query a non-redundant
protein database using in house MASCOT software (Matrix Science,
Boston, USA).2.2. Co-immunoprecipitation assays
To generate pECFL-HA-Cup, an EcoRI-EcoRI cup cDNA fragment
(encoding amino acids 2-1098) was inserted into the EcoRI site of the
pECFL-HA vector. To generate pcDNA3-Flag-Hsp83, the BclI-BclI
portion of the Hsp83 cDNA (encoding amino acids 21–687) was
inserted into the BamHI site of the pcDNA3–Flag vector (Invitrogen).
pMiranda–Myc is described in Piccioni et al. (2009).
Human embryonic kidney 293T cells (HEK293T) were cultured in
Dulbecco's modiﬁed Eagle's medium supplemented with 10% fetal
bovine serum (FBS) at 37 °C in a 5% CO2 atmosphere. Cells were
transiently co-transfected with 1 μg of appropriate plasmids using
FuGENE 6 (Roche Applied Science) in accordance with the manufac-
turer's instructions. Cells were lysed 48 h after transfection in lysis
buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0,1% Triton
X-100, 40 mM β-glycerophosphate, 2 mM orthovanadate, 1 mM PMSF,
10% glycerol, and protease inhibitor cocktail). 1 mg of total cell lysate
was pre-cleared with mouse IgG agarose beads (Sigma-Aldrich), and
then incubated overnight with 40 μl of 50% slurry anti-Flag agarose
beads (Sigma-Aldrich). After six washes in lysis buffer, at increasing
ionic strength, immunocomplexes were eluted by incubating the
beads with a Flag peptide (200 μg/ml) for 7 h at 4 °C. Samples were
reduced by boiling in standard Laemmli buffer, supplemented with
100 mM DTT, and then subjected to SDS-PAGE, followed by
immunoblotting with anti-HA or anti-Myc antibodies (Santa Cruz).
2.3. Drosophila strains
Flies were grown on standard sucrose–cornmeal–yeast food at
25 °C. Fly stocks were kindly provided by Dr. Stocker, Dr. Bopp, and by
Bloomington Drosophila Stock Center. Hsp8319F2 and Hsp83e6A alleles
are described by Yue et al. (1999); cup21 and cup15 alleles by Keyes and
Spradling (1997).
2.4. Ovary extracts
Drosophila ovarian protein extracts, derived from 3–5 day old
females, were obtained by douncing in 150 mM NaCl, 1% NP-40,
50 mM Tris pH 8.0, 5% glycerol, supplemented with a cocktail of
protease inhibitors (Roche).
2.5. Immuno-ﬂuorescence and DNA staining
Whole ovaries were dissected, ﬁxed, and incubated with anti-
bodies as previously described (Gigliotti et al., 1998). Rabbit anti-Cup
antisera were used at 1:200 dilution (Verrotti and Wharton, 2000);
mouse anti-Hsp90 3E6 (Carbajal et al., 1990) was used at 1:50 dilution.
Donkey anti-rabbit Alexa 488 and donkey anti-mouse Alexa 555 IgGs
(Molecular Probes) were used as secondary antibodies at 1:400
dilution. DNA staining was performed using Hoechst 33258 (Sigma-
Aldrich), as described by Zappavigna et al. (2004).
3. Results and discussion
3.1. Hsp90 is a component of the cap-binding complexes
In order to discover novel proteins involved in translational
regulation during Drosophila oogenesis, we performed a cap-binding
analysis. We used whole protein extracts from adult ovaries in afﬁnity
chromatography on m7GTP-Sepharose beads (Zapata et al., 1994;
Hernandez et al., 2005) and isolated approximately 30 candidates.
These proteins were separated by SDS/PAGE and identiﬁed by liquid
chromatography-tandem mass spectrometry (LC-MSMS; Fig. 1).
Several already known components of the active cap-binding
complex could be detected (Table 1), namely: eukaryotic translation
initiation factor 4E (eIF4E-1 and eIF4E-2; CG4035; Hernandez et al.,
Table 1
Cap-binding proteins identiﬁed by mass spectrometry
Bands Proteins Peptidesa % sequence coverageb
1 CG10811; eIF4G 64 50
CG11148 15 14
2 CG11181; Cup 39 50
3 CG18811 17 24
4 CG2238; EF2 16 27
CG5520; Glycoprotein 93 13 18
5 CG2331; TER94 10 18
6 GC9412; Rasputin 13 20
CG7035; Cbp80 11 18
7 CG1242; Hsp83 25 33
8 CG10686; Trailer hitch 5 11
9 CG4264; Hsc70-4 36 66
CG5119; PABP 11 25
10 CG4916; Me31B 21 46
CG6476; eIF-2γ 8 21
CG5654; Ypslon schachtel 9 33
CG1913; α-Tubulin 84B 6 22
11 CG12749; Hrb87F 10 28
CG9946; eIF-2α 6 19
12 CG8882; Trip1 6 25
CG9983; Hrb98DE 6 20
13 CG4035; eIF4E-1 6 37
14 CG6779; RpS3 15 58
CG17489; RpL5 11 33
CG2168; RpS3A 9 35
15 CG4035; eIF4E-2 6 29a
a Total number of peptides used for identiﬁcation.
b Percentage of sequence coverage for each identiﬁed protein.
Fig. 1. Proteomics of Drosophila cap-binding complexes from adult ovaries. Whole
protein extracts from Drosophila adult ovaries were used in afﬁnity chromatography on
m7GTP-Sepharose beads. Bound proteins were separated by SDS/PAGE and individual
protein bands (1–15) were identiﬁed by LCMS/MS analysis. The asterisk refers to
vitellogenic proteins.
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Hernandez et al., 1998); Poly(A) binding protein (PABP; CG5119;
Johnstone and Lasko, 2001); eukaryotic translation elongation factor
2b (EF-2; CG2238-PA; Grinblat et al., 1989); Suppressor of variegation
3–9 (eIF-2γ; CG6476-PB; Lasko, 2000); eukaryotic translation initia-
tion factor 2α (eIF-2α; CG9946; Lasko, 2000); Trip1 (eIF-3β; CG8882;
Lasko, 2000); Ribosomal protein S3 (RpS3; CG6779; Lyamouri et al.,
2002); Ribosomal protein S3A (RpS3A; CG2168; Lyamouri et al.,
2002); Ribosomal protein L5 (RpL5; CG17489; Coelho et al., 2005). We
further isolated Cap-binding protein 80 (Cbp80; CG7035), which
appears to replace eIF4E, for binding to the cap structure, during pre-
mRNA maturation and nonsense-mediated mRNA decay processes
(Maquat, 2004).
We could also identify speciﬁc factors whose involvement in
translational repression mechanisms and/or localization of select
mRNAs, during egg chamber development, had been either previously
demonstrated or predicted (Table 1): Cup (CG11181; Piccioni et al.,
2005); Maternal expression at 31B (Me31B; CG4916; Nakamura et al.,
2001; Barbee et al., 2006); Trailer hitch (Tral; CG10686;Wilhelm et al.,
2005; Barbee et al., 2006); Ypsilon schachtel (Yps; CG5654; Wilhelm
et al., 2000; Mansﬁeld et al., 2002); TER94 (CG2331; Ruden et al.,
2000; Thomson et al., 2008); Rasputin (CG9412; Giot et al., 2003);
Heterogeneous nuclear ribonucleoprotein at 87F (Hrb87F; CG12749;
Giot et al., 2003); Heterogeneous nuclear ribonucleoprotein at 98DE
(Hrb98DE; CG9983-PB; Giot et al., 2003).
Furthermore, we identiﬁed three members of the heat shock
protein superfamily (Table 1): Glycoprotein 93 (Gp93; CG5520;
homolog to human Endoplasmin, a member of the Hsp90 family);
Heat shock protein 83 (Hsp83, hereafter called Hsp90; CG1242; Hartl,1996); and Heat shock protein cognate 4 (Hsc70-4; CG4264; Perkins et
al., 1990). Finally, three other factors, whose functional correlation
with translational control is unclear, were found:α-Tubulin at 84B (α-
Tub84B; CG1913; Hutchens et al., 1997), CG11148-PA, and CG18811.
As mentioned above, Hernandez et al. (2005) used a similar
functional proteomic approach to identify proteins present in cap-
binding complexes derived from Drosophila embryos. A comparison of
the cap-binding analysis in embryos (Hernandez et al., 2005) and
ovaries (this work) reveals the isolation of positive regulators of
eukaryotic translation in higher percentage from embryos, but few of
them (including eIF4E, eIF4G, PABP, Cbp80, Trip1 and RpS3) coincide.
One possible explanation of this result is that the authors used 0–
18 hour-old embryo extracts, a relatively broad developmental
window when both maternally inherited and zygotically transcribed
mRNAs are actively translated. On the contrary, during oogenesis
several mRNAs (e.g. nanos and oskar) are known to be both negatively
and positively regulated at the translational level to guarantee proper
egg chamber development. Additional shared interactors isolated
with the two afﬁnity puriﬁcation assays include α-Tub84B and two
proteins putatively involved in RNA metabolism: Hsc70-4 (Dorner et
al., 2006) and Hrb87F (Zu et al., 1996).
Our approach also identiﬁed Cup, a known negative regulator of
translation and eIF4E-binding molecule, and a few of its interactors:
Rasputin (Giot et al., 2003); Me31b (Giot et al., 2003; Wilhelm et al.,
2005; Thomson et al., 2008); Tral (Wilhelm et al., 2005); Yps (Wilhelm
et al., 2003). In addition, we isolated TER94 another protein involved in
mRNA localization/translation (Thomson et al., 2008). It is interesting
to notice thatmost of the available data from the literature point to osk
(and/or grk) mRNA(s) as the primary molecular target of the above
mentioned factors. It remains an open question if and how other
mRNAs might be regulated by Cup at the translational level within the
Drosophila ovary. However, a series of genetic data (Keyes & Spradling,
1997; Zappavigna et al., 2004) suggest that this might be true.
3.2. Effects of Hsp83 mutant alleles on oogenesis
Among the isolated components of the cap-binding complexes, we
decided to focus our attention on Hsp90, a hub molecular chaperone
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literature show that it is involved in mRNA localization mechanisms
during Drosophila early embryogenesis (Song et al., 2007). Subcellular
mRNA localization often assures restricted protein synthesis (Sey-
doux, 1996; Johnstone and Lasko, 2001; St Johnston, 2005), thus
Hsp90 might also act as a translational regulator of select mRNAs
during oogenesis.
In order to investigate the role of Hsp90 during oogenesis, we ﬁrst
analyzed the ovarian phenotype of ﬂies bearing diverse Hsp83mutant
alleles. Most of the known Hsp83 mutant alleles are homozygous
lethal, however some are trans-heterozygous viable and display a
sterile phenotype in males and either a sterile or a weakly fertile
phenotype in females (Yue et al., 1999). We used the Hsp83 alleles e6A
and 19F2 (S592F and R48C respectively, according to their amino acid
substitution) that cause, in trans-heterozygous combination, a
dramatic reduced viability (b1%) and a full female sterility (Yue et
al., 1999).
Hsp83e6A/Hsp8319F2 mutant female ﬂies display a series of ovarian
defects (Fig. 2). Most egg chambers (approximately 75%) are blocked
at different developmental stages, not exceeding stage 9 (Fig. 2, panel
A). The remaining egg chambers show a pronounced defect during the
transfer of the nurse cell cytoplasm into the developing oocyte, a
process named dumping and starting around stage 10B of oogenesis.
In Hsp83e6A/Hsp8319F2 mutant egg chambers, the nuclei of the nurseFig. 2. Effects of Hsp83 mutant alleles on oogenesis. Hsp83e6A/Hsp8319F2 females are weakly
chambers (approximately 75%) are blocked in their development during mid-oogenesis (p
process (panels B and C). Hoechst-staining (panels A and B) and dark ﬁeld (panel C) images ar
in size when compared to their heterozygous, wild-type counterparts (panel E); these twocells do not degenerate at the end of the dumping process, as it
normally occurs, but persist up to the latest stages of oogenesis, when
the formation of the chorion culminates in the synthesis of the dorsal
appendages (Fig. 2, panels B and C). Moreover, mutantmature eggs are
smaller in size with altered dorsal appendages when compared to
their heterozygous, wild-type counterparts (Fig. 2, panels D and E).
The oogenesis defects described above resemble a few of the
diverse morphological alterations displayed by a number of cup
alleles. In particular, the weakest group of cup alleles (class III)
produces defective eggs reduced in volume, besides being character-
istically shaped like cups (Keyes and Spradling, 1997).
3.3. Hsp90 and Cup co-localize in vivo and interact in vitro
In order to analyze the spatio-temporal expression pattern of the
Hsp90 protein and to compare it with the expression pattern of Cup,
we performed immuno-localization experiments onwild-type ovaries
using either monoclonal anti-Hsp90 or polyclonal anti-Cup
antibodies.
As shown in Fig. 3A (left panel), the Hsp90 protein is detected
within the cytoplasm of both somatic and germ-line derived cells
throughout oogenesis, thus suggesting a ubiquitous mode of action of
Hsp90 during egg chamber development. On the contrary, the Cup
protein is restricted to the cytoplasm of all germ-line cells and isviable (b1%) and fully sterile (Yue et al., 1999). The majority of Hsp83e6A/Hsp8319F2 egg
anel A). The remaining egg chambers show a pronounced defect during the dumping
e not on scale. In addition, dark ﬁeld images showmutant mature eggs (panel D) smaller
last pictures are on scale.
Fig. 3. Hsp90 co-localizes with Cup within wild-type germaria. Single confocal sections of wild-type egg chambers, doubly immunostained with anti-Hsp90 (red) and anti-Cup
(green) antibodies, are shown. (A) Hsp90 (left panel) is distributed within the cytoplasm of both somatic and germ-line derived cells throughout oogenesis; Cup (right panel)
accumulates at the posterior cytoplasm of developing oocytes (up to stage 8), around the nurse cell nuclei (in early egg chambers), and in the nurse cell cytoplasms; (B) Cup and
Hsp90 show a similar dynamic proﬁle of expression within the germarium. The two proteins co-localize in the cytoplasm of the germ-line stem cells (region 1, R1), are almost
undetectable in the cystoblast cleavage stages (anterior portion of region 2, R2), and rise again to relatively high levels in the posterior portion of region R2 and in the germ-line
maturing cysts (region 3, R3).
Fig. 4. Hsp90 associates speciﬁcally with Cup. Co-immunoprecipitation assays. (A)
HEK293T-transfected cells expressingHA-Cup in thepresenceof Flag–Hsp83or Flag alone.
An anti-Flag antibody co-immunoprecipitates HA-Cup fusion protein speciﬁcally when
cells are co-transfected with Flag–Hsp90 and HA–Cup expressing vectors (lane 1), but the
same antibody fails to co-immunoprecipitate HA–Cup in a control reaction (lane 3). (B)
HEK293T cells co-transfected with Flag–Hsp90 and Miranda–Myc expressing vectors. An
anti-Flag antibody immunoprecipitates Flag–Hsp90 efﬁciently (lane 1, bottom panel), but
does not co-immunoprecipitate Miranda–Myc (lane 1, top panel), All transfected cells
show high-levels of expression of tagged proteins (input lanes).
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stage 8 (Fig. 3B, right panel). Moreover, Cup surrounds the nurse cell
nuclei in early egg chambers and by stage 10most of the protein lies in
the nurse cell cytoplasm. These observations indicate only that the
distribution patterns of the two proteins overlap within selected area,
including the oocyte posterior cytoplasm.
It is worth noticing, however, that both Hsp90 and Cup levels are
speciﬁcally modulated in the initial phases of germ-line development,
which occur within the anterior tip of the ovariole, called germarium,
where germ-line stem cells divide asymmetrically to give rise to
cystoblasts, successively developing into cysts (Fig. 3A; Keyes and
Spradling, 1997; Verrotti and Wharton, 2000). This is better
appreciated in double immunoﬂuorescence experiments, performed
using anti-Cup and anti-Hsp90 antibodies on wild-type ovaries (Fig.
3B). In region 1 (R1), both proteins are present in the germ-line stem
cells and cystoblasts, become almost undetectable during cystoblast
cleavage stages in the anterior portion of region 2 (R2), and rise again
to relatively high levels in the posterior portion of R2 and in region 3
(R3), where the germ-line maturing cysts are located. The coincident
spatio-temporal distribution of Cup and Hsp90, within stem cells, late
cystoblasts, and maturing cysts of the germarium, suggests that the
two proteins may play a common function at least during the earliest
stages of oogenesis.
To demonstrate that a physical interaction occurs between Hsp90
and Cup, HEK293T cells were co-transfected with plasmids encoding
HA–Cup and Flag–Hsp90 or Flag alone. As shown in Fig. 4A, the anti-
Flag antibody co-immunoprecipitates HA–Cup when cells were co-
transfected with HA–Cup and Flag–Hsp90 expressing vectors. On the
contrary, the same antibody fails to co-immunoprecipitate HA–Cup
72 V. Pisa et al. / Gene 432 (2009) 67–74when Flag alone and HA-Cup expressing vectors were co-transfected.
In addition, to exclude the possibility that Hsp90 might act as a
chaperone on some fraction of misfolded Cup, thus accounting for the
biochemical interaction described above, we veriﬁed its binding
ability on Miranda, a protein known to speciﬁcally interact with Cup
(Piccioni et al., 2009). To this aim, we co-transfected HEK293T cells
with plasmids encoding Miranda–Myc and Flag–Hsp90 and demon-
strated that the anti-Flag antibody fails to co-immunoprecipitate
Miranda–Myc (Fig. 4B).
Next, we wished to determine whether or not the interaction
between Hsp90 and Cupmight be direct. To test these possibilities, we
performed a yeast two-hybrid assay using three different portions of
the Hsp90 protein (corresponding to amino acids 21–687, 21–717, and
2–717) fused to the activation domain (AD) of GAL4 and full-length
Cup (amino acids 2–1132) protein fused to the GAL4 DNA-bindingFig. 5. Hsp83 and cup interact genetically. Morphological analysis of homozygous cup21 and
mutant ovaries in combination with diminished Hsp90 activity, by using either Hsp83e6A or
stained egg chambers to visualize nuclei. Note that all double heterozygous combinations bdomain (DBD). Although corrected expressed, none of these Hsp90
AD-fusions interacts with Cup in yeast (data not shown).
Altogether, these data demonstrate that Hsp90 is a component of
the cap-binding complexes and a novel Cup-interactor, but also
suggest that the interaction with Cup is indirect and consequently
mediated by other factors. It is therefore likely that one or more of the
proteins identiﬁed with the functional proteomic approach described
above are responsible for this interaction.
3.4. Hsp83 interacts genetically with cup
Cup is a playmaker during female germ-line development: its
interaction with ovarian tumor (otu) is required for the structure and
function of germ-line chromosomes (Keyes and Spradling, 1997); the
association with Nanos is necessary for the maintenance and survivalcup15 (as representative of the weak and intermediate class of cup alleles, respectively)
Hsp8319F2 mutant allele. The panel displays ﬂuorescence microphotographs of Hoechst-
ehave as wild-types.
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interaction with eIF4E is required to control development and growth
of ovaries (Zappavigna et al., 2004); it cooperates with Miranda to
assure proper egg chamber development (Piccioni et al., 2009).
Moreover, during oogenesis, Cup acts as a translational repressor
directly associating with eIF4E and/or 3′-untraslated region (UTR)-
bound factors, thus silencing osk and grk mRNAs (Whilhelm et al.,
2003; Nakamura et al., 2004; Clouse et al., 2008).
However, the studies reported so far do not explain all the
phenotypes shown by the different cup mutant alleles available,
suggesting that Cup associates with multiple factors to accomplish its
numerous roles. Our results suggest that Hsp90 is a novel Cup-
interactor duringDrosophila oogenesis. Thus, we askedwhether or not
Hsp83 and cup might interact genetically during egg chamber
development.
To address this question, we lowered the level of Hsp90 activity
and looked for any modiﬁcation of the ovarian phenotypes associated
with different cup mutations. Whereas Hsp83 mutant alleles (at least
those used in this study) are homozygous lethal, cup mutant alleles
are homozygous viable and grouped into three classes, based on the
severity of their oogenesis defects (Keyes and Spradling, 1997). On the
other hand, both Hsp83 and cup alleles are fully recessive, thus
behaving as wild-types when in heterozygous conditions.
In our studies, we used cup21 and cup15 as representative of classes
III and II of cup alleles respectively. Class III includes the weakest cup
alleles, which display characteristic cup-shaped mature eggs and
dwarf oocytes; while the intermediate class II alleles show egg
chamber growth arrest around stages 7–8 and abnormal chromatin
conﬁguration (Keyes and Spradling, 1997). The two cupmutant alleles
were tested in combination with either Hsp83e6A or Hsp8319F2 mutant
alleles, previously shown to behave as trans-heterozygous female
sterile.
On a morphological level, all Hsp83 alleles tested exacerbate the
oogenesis defects associated with both class III and class II cup alleles,
as shown by Hoechst staining (Fig. 5). The reduction of Hsp83 activity,
in a cup21 genetic background, results in earlier egg chamber growth
arrest (around stages 4–5) and precocious degeneration of the nurse
cell nuclei, which appear already altered at stages 2–3, when
compared to homozygous cup21 control ovaries. Moreover, cup21/
cup21;Hsp83/+ germaria are often misshapen, with egg chambers
either unbudded or fused, as underlined by the presence of super-
numerary nurse cell nuclei (Fig. 5, left panels). Similar defects are also
displayed by cup15/cup15;Hsp83/+ ovaries when compared to homo-
zygous cup15 controls (Fig. 5, right panels). 33% (75/227) of cup21/
cup21;Hsp83/+ egg chambers stop development around stage 4; the
remaining 67% (152/227) of these egg chambers are fused. On the
contrary, only 12% (19/157) of cup21/cup21 control ovaries arrest their
development around stage 4, and no signiﬁcant fusion rate is
observed. Comparable frequencies and types of defects are observed
in cup15/cup15;Hsp83/+ egg chambers when compared to cup15/cup15
controls. Taken together, these results indicate a bona ﬁde genetic
interaction between Hsp83 and cup. This genetic interaction is not
allele-speciﬁc since two different Hsp83 alleles deteriorate the ovarian
phenotype displayed by two distinct cup alleles.
Finally, we tested whether or not the amount or distribution of the
Cup protein are altered in Hsp83e6A/Hsp8319F2 mutant female ovaries.
As demonstrated by Western blot of total ovary extracts, Cup protein
levels were not reduced in Hsp83 mutants when compared to their
wild-type counterparts (data not shown). However, in 3–5% of stage 9
Hsp83e6A/Hsp8319F2 egg chambers Cup did not appear tightly localized
to the posterior pole of developing oocytes.
The biochemical and genetic interactions we observed between
Hsp90 and Cup suggest that the protein complex formed by these two
proteins might mediate localization/translation of select mRNAs
during egg chamber development. This hypothesis is corroborated
by the ﬁnding that Hsp90 is required for mRNA localization duringembryogenesis (Song et al., 2007). However, we cannot exclude that
Hsp90 could also act as a hubmolecular chaperone contributing to the
proper structure and/or function of other proteins involved in
localization/translation of speciﬁc mRNAs during oogenesis.
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